Shuibing Chen, PhD

Dr. Chen is an Associate Professor in the Department of Surgery at Weill Cornell Medical College, where she focuses on manipulating stem cell fate using chemical and biological approaches and generating functional tissues and organs that can be used for translational research. Her lab’s goal is to use these patient-specific tissues and organs for replacement therapy, particularly in diabetes. She conducted her postdoctoral studies at Harvard University, where she studied the directed differentiation of human embryonic stem cells toward the pancreatic lineage.

• PubMed Profile
• Dr. Chen's Lab Website

• Diabetes

• Stem Cell Models Point to New Treatment Avenues for Pancreatic Cancer
• New Frontiers in Regenerative Medicine: Highlights of the 2023 NYSCF Conference
• What Makes Someone a Likely Target of a Virus?
• Translating Discoveries into Medicine, Advancing Equity in Science, and New Cancer Therapies: Watch Highlights of the 2021 NYSCF Conference
• The Stem Cell Science You Won’t Want to Miss at The NYSCF Conference
• Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
• Experts Discuss the Latest in COVID-19 Research: Everything from Immunity to Stem Cells to Vaccines
• All Your Questions About the Science of COVID-19, Answered – Plus How Stem Cells Can Help
• New Solutions Are on the Horizon for COVID-19: Here’s How the NYSCF Community is Uniting to Push Them Forward
• Translational Research Takes Center Stage at NYSCF Conference
• International Society for Stem Cell Research Conference Showcases Promising Progress
• Modeling the Digestive Tract using Stem Cells
• NYSCF Innovator Makes Step Towards Therapies for Metabolic Diseases
• NYSCF Innovator Finds New Small Molecule Activator for Stem Cell Differentiation
• NYSCF - Robertson Investigator Studies Pancreatic Development Using Stem Cells